Orsay, France

Jean-Marie Miquet

This inventor holds 2 USPTO granted patents. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marie Miquet. Retrieved from https://idiyas.com/inventor/jean-marie-miquet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Marie Miquet

Introduction

Jean-Marie Miquet is a notable inventor based in Orsay, France. He has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. With a total of 2 patents to his name, Miquet's work has the potential to impact many lives.

Latest Patents

Miquet's latest patents include the "Application of riluzole in the treatment of Parkinson's disease" and the "Application of carbamazepine and oxcarbazepine in the treatment of various conditions." These innovations showcase his dedication to advancing medical treatments and improving patient outcomes.

Career Highlights

Jean-Marie Miquet is currently associated with Rhone-Poulenc Rorer S.A., a company known for its commitment to pharmaceutical research and development. His work at this organization has allowed him to focus on groundbreaking research that addresses critical health issues.

Collaborations

Miquet has collaborated with esteemed colleagues such as Mireille Meunier and Erik Louvel. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of their collective research efforts.

Conclusion

Jean-Marie Miquet's contributions to the field of medicine through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treatment options for neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…